Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Fidock

Showing results (131-140 of 303) with videos related to

Pageof 31
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2005
Disruption of a Plasmodium falciparum gene linked to male sexual development causes early arrest in gametocytogenesisTetsuya Furuya, Jianbing Mu, Karen Hayton, et al.
Analytical Chemistry|August 8, 2014
Multicolor bioluminescence boosts malaria research: quantitative dual-color assay and single-cell imaging in Plasmodium falciparum parasitesLuca Cevenini, Grazia Camarda, Elisa Michelini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2020
A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048James S McCarthy, Cristina Donini, Stephan Chalon, et al.
Plos Pathogens|June 7, 2019
Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agentsBarbara H Stokes, Euna Yoo, James M Murithi, et al.
Nature Communications|August 18, 2018
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquineLeila S Ross, Satish K Dhingra, Sachel Mok, et al.
Cell Chemical Biology|December 10, 2019
Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug DiscoveryJames M Murithi, Edward S Owen, Eva S Istvan, et al.
Nature Communications|September 24, 2020
Genetic screens reveal a central role for heme metabolism in artemisinin susceptibilityClare R Harding, Saima M Sidik, Boryana Petrova, et al.
Cellular Microbiology|February 21, 2013
Spatial and temporal mapping of the PfEMP1 export pathway in Plasmodium falciparumPaul J McMillan, Coralie Millet, Steven Batinovic, et al.
Science (New York, N.Y.)|August 6, 2011
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targetsJing Yuan, Ken Chih-Chien Cheng, Ronald L Johnson, et al.
Molecular Microbiology|June 22, 2007
Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasitesPaul Hunt, Ana Afonso, Alison Creasey, et al.
Pageof 31

Showing results (131-140 of 303) with videos related to

Sort By:
Pageof 31
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2005
Disruption of a Plasmodium falciparum gene linked to male sexual development causes early arrest in gametocytogenesisTetsuya Furuya, Jianbing Mu, Karen Hayton, et al.
Analytical Chemistry|August 8, 2014
Multicolor bioluminescence boosts malaria research: quantitative dual-color assay and single-cell imaging in Plasmodium falciparum parasitesLuca Cevenini, Grazia Camarda, Elisa Michelini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2020
A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048James S McCarthy, Cristina Donini, Stephan Chalon, et al.
Plos Pathogens|June 7, 2019
Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agentsBarbara H Stokes, Euna Yoo, James M Murithi, et al.
Nature Communications|August 18, 2018
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquineLeila S Ross, Satish K Dhingra, Sachel Mok, et al.
Cell Chemical Biology|December 10, 2019
Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug DiscoveryJames M Murithi, Edward S Owen, Eva S Istvan, et al.
Nature Communications|September 24, 2020
Genetic screens reveal a central role for heme metabolism in artemisinin susceptibilityClare R Harding, Saima M Sidik, Boryana Petrova, et al.
Cellular Microbiology|February 21, 2013
Spatial and temporal mapping of the PfEMP1 export pathway in Plasmodium falciparumPaul J McMillan, Coralie Millet, Steven Batinovic, et al.
Science (New York, N.Y.)|August 6, 2011
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targetsJing Yuan, Ken Chih-Chien Cheng, Ronald L Johnson, et al.
Molecular Microbiology|June 22, 2007
Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasitesPaul Hunt, Ana Afonso, Alison Creasey, et al.
Pageof 31